Jim Cramer: 'there are a lot of issues' with Constellation Brands stock
Constellation Brands (STZ) reported Q2 earnings of $3.74 per share on $2.63 billion sales, beating estimates but keeping guidance unchanged. Shares initially fell but recovered after management indicated potential for top-end fiscal 2027 results. Jim Cramer remains bearish, citing challenges like GLP-1 treatments and beer margin pressures. STZ is acquiring SpikedAde for up to $353 million, raising concerns about balance sheet strain. Analysts rate STZ overweight with a mean price target of $160.
How this was made
The 30-second read
Why it matters
The earnings beat is offset by a lack of guidance lift and a bearish media narrative, suggesting limited upside.
Market read
Earnings release with mixed signals; potential short‑term price pressure.
What to watch
The $75M SpikedAde acquisition may add incremental growth if the product gains traction.
Background
Jim Cramer’s commentary follows Constellation Brands’ Q2 earnings release, highlighting unchanged guidance and a $75M acquisition.
Ticker impact
Constellation Brands reported Q2 earnings beating estimates with $3.74 EPS and $2.63B sales, but guidance unchanged, prompting Cramer caution.
likely modest downside as investors digest the lack of guidance raise and Cramer’s warning
The fresh earnings numbers are material, but the absence of an outlook upgrade and a high‑profile bearish note suggest pressure rather than a rally.
Market effects
Beer, wine and spirits sector may see broader scrutiny on margins and growth prospects.
U.S. consumer discretionary sentiment could soften amid weight‑loss treatment trends affecting alcohol demand.
Limited; primarily impacts U.S. listed beverage stocks.
Counterpoint
Despite Cramer’s caution, the earnings beat and strong cash flow could support a short‑term bounce.
Key entities
- companyConstellation Brands
U.S. beverage company (ticker STZ) reporting Q2 results.
- personJim Cramer
Host of Mad Money, providing market commentary.
